These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Vascularized composite allograft-specific characteristics of immune responses. Issa F. Transpl Int; 2016 Jun; 29(6):672-81. PubMed ID: 26927941 [Abstract] [Full Text] [Related]
5. The Effect of MHC Antigen Matching Between Donors and Recipients on Skin Tolerance of Vascularized Composite Allografts. Shanmugarajah K, Powell H, Leonard DA, Mallard C, Albritton A, Harrington E, Randolph MA, Farkash E, Sachs DH, Kurtz JM, Cetrulo CL. Am J Transplant; 2017 Jul; 17(7):1729-1741. PubMed ID: 28035752 [Abstract] [Full Text] [Related]
11. Composite Graft Pretreatment With Hydrogen Sulfide Delays the Onset of Acute Rejection. Fries CA, Lawson SD, Wang LC, Spencer JR, Roth M, Rickard RF, Gorantla VS, Davis MR. Ann Plast Surg; 2019 Apr; 82(4):452-458. PubMed ID: 30628928 [Abstract] [Full Text] [Related]
14. Inhibition of Lymphatic Drainage With a Self-Designed Surgical Approach Prolongs the Vascularized Skin Allograft Survival in Rats. Pei J, Li Y, Chen C, Zhang X, Wang S, Song Y, Liu B, Su Y, Guo S. Ann Plast Surg; 2018 Jan; 80(1):76-82. PubMed ID: 28930779 [Abstract] [Full Text] [Related]
15. Depletion of donor dendritic cells ameliorates immunogenicity of both skin and hind limb transplants. Ashraf MI, Mengwasser J, Reutzel-Selke A, Polenz D, Führer K, Lippert S, Tang P, Michaelis E, Catar R, Pratschke J, Witzel C, Sauer IM, Tullius SG, Kern B. Front Immunol; 2024 Jan; 15():1395945. PubMed ID: 38799435 [Abstract] [Full Text] [Related]
16. Local Immunosuppression for Vascularized Composite Allografts: Application of Topical FK506-TyroSpheres in a Nonhuman Primate Model. Gama AR, Ng ZY, Shanmugarajah K, Mastroianni M, Randolph MA, Lellouch AG, Kohn J, Cetrulo CL. J Burn Care Res; 2020 Nov 30; 41(6):1172-1178. PubMed ID: 32352521 [Abstract] [Full Text] [Related]
17. Immunomodulatory Strategies Directed Toward Tolerance of Vascularized Composite Allografts. Madariaga MLL, Shanmugarajah K, Michel SG, Villani V, Muraglia GM, Torabi R, Leonard DA, Randolph MA, Colvin RB, Yamada K, Madsen JC, Cetrulo CL, Sachs DH. Transplantation; 2015 Aug 30; 99(8):1590-1597. PubMed ID: 25757218 [Abstract] [Full Text] [Related]
18. Vascularized Composite Allotransplantation: A Functional Hind Limb Model in Mice. Vernon R, Wang J, Song M, Wilson N, Moris D, Cendales L. J Surg Res; 2020 Jun 30; 250():119-124. PubMed ID: 32044508 [Abstract] [Full Text] [Related]
19. Humoral Alloreactivity in VCA Recipients: Should We Learn From Our Experience? Sicard A, Kanitakis J, Dubois V, Morelon E, Thaunat O. Transplantation; 2020 Oct 30; 104(10):2003-2010. PubMed ID: 32039965 [Abstract] [Full Text] [Related]
20. Defining chronic rejection in vascularized composite allografts - do we have reliable surrogates to look for? Kanitakis J. Curr Opin Organ Transplant; 2023 Dec 01; 28(6):440-445. PubMed ID: 37811863 [Abstract] [Full Text] [Related] Page: [Next] [New Search]